
PhD candidate studying the role of somatic mutations in human aging with Vijg & Sidoli Labs @EinsteinMed
Bronx, NY
Joined June 2018
- Tweets2.8K
- Following995
- Followers529
- Likes4.9K
CAGE ok
RNA-seq no ok
amazing work showing that predictions from different tracks of seq2exp models do not reflect a coherent model of transcription
biorxiv.org/content/10.64898…
162
Kudos
A scorched-earth approach to aging research by Rich Miller 🔥
Pretty much everything gets criticised, from the hallmarks of aging to cell senescence, epigenetic clocks, and cellular rejuvenation.
But Rich makes some very good points. I particularly like the Rolex analogy regarding aging clocks.
If you’re working in aging science, please read it and thank me later! It's an entertaining and much-needed critical perspective.
For the record, I was a reviewer of this paper, and suggested a little more nuance and balance. My suggestions didn't make it to the final version, though. Why be balanced when you can just burn everything in your path! 🔥
link.springer.com/article/10…
96
Alex demonstrates how basic evolutionary logic will give you a stark but realistic view of damage accumulation and the costs of living. The fields needs more of this. Maybe without the exception of, “even people get sacrificed to make room for the new generation” 🤣
Most of the cells in your body are younger than you are. Yet, you still age. Why?
I explore this in my new post. Link in the reply.
1
1
126
Finally, confidence scores!
AlphaGenome made predictions for all 9B single nucleotide variants, but can you trust them? The models are still far from accurate!
Check out our updated preprint (now a full paper, upgraded from our early pre-CSHL AI symposium draft):
biorxiv.org/content/10.64898…
1
150
Some seem more like engineering problems but aging seems more in reach than figuring out the origin of life
In light of the progress in mathematics, we at Edison Scientific and FutureHouse have assembled a set of Millennium Problems for Biology. They are chosen to be very hard to solve but very easy to validate in a simple laboratory environment. Any of these, if solved, would mark a major advance in biotechnology, and most of them would contribute materially towards curing disease. These are, in some sense, the “last reasonable eval” for AI in biology. This was work primarily by @MichaelaThinks and myself, with contributions from many others.
Short descriptions below. The full descriptions of the problems with acceptance criteria are at the Bio Millennium Problems website, linked in the next post. Share more if you have ideas. If they meet our criteria, we’ll add them to our list (with attribution and permission).
98
Im sorry RNA
Same single cell, two modalities—both at depth. We digest protein first, run Smart-seq3xpress + C18 (Evotip) separation: peptides captured, cDNA in flowthrough. In HeLa & stem cells, proteome tracks cell state; RNA variance flags transitioning cells.
biorxiv.org/content/10.64898…
187
Just use mass spec
The scientific community is grappling with concerns about the reliability of these workhorse antibodies
go.nature.com/4hOHZDt
1
118
While the datasets produced are impressive and will become a valuable resource, just because you see convergence of gene expression and chromatin accessibility does not mean that the upstream driver is akin to a developmental program @junyue_cao
Is aging simply decay? Not to cell biologist Junyue Cao, who believes the process is far more orderly: “The destruction of the system is programmed at a very early stage.” quantamagazine.org/why-aging…
3
274
Very cool!
RNA-seq tells us how much RNA is present in the cell. But to understand gene regulation, we need to easily measure the synthesis and decay rates driving this abundance. We introduce AIR-seq: analog intrinsic recoding sequencing. (1/6) biorxiv.org/content/10.64898…
2
258
How do you explain how cells get age-related cancer or why irradiated mice/people (also smokers) show accelerated aging? The adaptive programs allow an organism to stave off entropy until its genes are passed on
Aging is not primarily driven by molecular damage or the hallmarks, but instead result from developmental programs that run on beyond their adaptive purpose, gradually reducing cell proliferation, plasticity, and tissue regeneration.
2
4
1,595
Just use mass spec
Pretty interesting story in @ScienceMagazine this week on what looks like a serious problem in the senescence field. More than 400 papers apparently used the wrong antibody for p16-INK4a — an antibody that actually recognizes a completely different, unrelated protein (a component of the actin cytoskeleton). This affects work on senescent cell accumulation in aging and disease, and most critically, some of the evidence base for senolytic drug research.
What concerns me most is that many of these papers somehow got the "right" answer using the wrong antibody. That's not just an innocent reagent mix-up — it raises real questions about data fabrication or selective reporting in at least some of these labs. I've commented before about how ignoring data that doesn't fit the narrative is a major problem in certain areas of the longevity literature (e.g. sirtuins and NAD), and here a potentially widespread example in senescence.
Hopefully journals will investigate and retract as necessary, but based on my experience that seems optimistic. One concrete fix is that journals should flag problematic antibody product codes at submission so reviewers can catch this before publication. Reviewers should absolutely be on the lookout for this going forward.
However, these fixes won't address the larger problem. We need to understand how these scientists got the results they wanted and published them over 400 times (!!!): whether through intentional deception, incompetence, accident, or some legitimate explanation.
Credit for discovering this goes to @addictedtoigno1 who wrote about it first on his blog: For Better Science
science.org/content/article/…?
63
🤯
Excited to share our latest paper, out today @CellCellPress. We found that large pieces of the human genome can transfer between cells upon direct contact, endowing recipient cells with heritable phenotypic changes. (1/7)
cell.com/cell/fulltext/S0092…
1
159
Very cool! Gap filling is a clever idea
We’re unwrapping a new method today @MSKCancerCenter!
Led by @SydneyBlattman, @NabihMaslah, @AustinAVarela, Ronan Chaligne and @dana_peer, plus colleagues at @10xGenomics, we’re delighted to share Genotyping In Fixed Transcriptomes (GIFT):
biorxiv.org/content/10.64898…
1/n
1
100
Super cool
What would it look like to see all ~13,000 proteins inside a single human cell at once?
We share ProtiCelli — a generative model that makes this possible. Besides benchmarking, we demonstrate utility in many tasks.
Preprint: bit.ly/3NY175q
A thread 🧵👇
1
135
Thoughtful piece, “Aging is the interaction between stochastic damages and the programmed defenses against them.”
I wrote a piece on why aging is not fundamentally programmed, and why gene regulation still matters despite that.
olafurpall.substack.com/p/wh…
1
3
158



















